Results 121 to 130 of about 189,087 (191)

Treatment Cessation in Patients with Diabetic Maculopathy under Intravitreal Anti-VEGF Therapy Following a Treat-and-Extend Protocol. [PDF]

Ophthalmol Sci
Saucedo L, Pfister IB, Schild C, Garweg JG.   +3 more
europepmc   +1 more source

Palmerston North Interventional Rapid Avastin Treat and Extend (PIRATE) study protocol; meeting the medical retina service needs of our ageing population. [PDF]

BMJ Open Ophthalmol, 2023
Bonnet LA, Singh V, Ah-Chan J.
europepmc   +1 more source

One-year outcomes of the treat-and-extend regimen using aflibercept for the treatment of diabetic macular edema. [PDF]

J Chin Med Assoc, 2022
Sheu SJ, Yang CH, Lai CC, Wu PC, Chen SJ.   +4 more
europepmc   +1 more source

A multicenter, single-arm study using a modified faricimab treat-and-extend regimen in patients with macular edema due to central retinal vein occlusion: RVOSTAR study design protocol. [PDF]

PLoS One
Kondo M, Shimura M, Tsujikawa A, Muraoka Y, Kogo T, Akiyama Y, Hama Y, Tsujimura J, Iwasaki K, Kamei M.   +9 more
europepmc   +1 more source

Novel metrics for evaluating decision making in a 'Treat and Extend' regimen for neovascular age related macular degeneration. [PDF]

Eye (Lond), 2022
McLeish B, Morris A, Karpoor M, Babar T, Narendran N, Yang Y.   +5 more
europepmc   +1 more source

Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration:Results with Ranibizumab from the TREND Study [PDF]

, 2018

core   +1 more source

Aflibercept for central retinal vein occlusions: long-term outcomes of a 'Treat-and-Extend' regimen. [PDF]

BMJ Open Ophthalmol
Jaggi D, Nagamany T, Wolf S, Zinkernagel MS, Heussen FM.   +4 more
europepmc   +1 more source

Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials. [PDF]

Ophthalmol Ther
Friedman SM, Xu Y, Sherman S, Kuznik A, Mojebi A, Keeping S, Chan K, Leng T, Patel N.   +8 more
europepmc   +1 more source

Infographic: Efficacy and safety of intravitreal aflibercept treat-and-extend regimens in exudative age-related macular degeneration: ALTAIR study. [PDF]

Eye (Lond)
Barai I, Mathew RG, Sivaprasad S, Henein C.   +3 more
europepmc   +1 more source

Two-year Outcomes of Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration with "Observe before Treat-and-Extend" Method. [PDF]

Korean J Ophthalmol
Moon JY, Kim HJ, Cho SC.
europepmc   +1 more source